Features
Management of the Primary Angle-closure Suspect
Observation, laser peripheral iridotomy, or cataract surgery can all be viable options.
By Ameay V. Naravane, MD, James C. Liu, MD
Lower IOP in Cataract Surgery
Migrating to more physiologic intraocular pressures during surgery improves chamber stability, recovery, and patient comfort.
By Matthew P. Rauen, MD
Telehealth for Glaucoma
For some underserved patients, telehealth may present a viable option for managing their disease without compromising clinical outcomes.
By Imani Nwokeji, , Lorraine M. Provencher, MD
Targeting Episcleral Venous Pressure to Reduce IOP
By directly targeting distal outflow and EVP, ATP-sensitive potassium channel openers like QLS-111 could redefine treatment.
By Michael P. Fautsch, PhD, Barbara M. Wirostko, MD, FARVO
Advocating for Preservative-free Glaucoma Drops
The Preservative Freedom Coalition wants physicians and patients to understand how preservative-free medications can improve ocular surface health.
By Jim Gallagher, senior managing editor
Web Exclusives
New Developments in Medical Therapy
Sustained-release strategies and drugs that target episcleral venous pressure hold promise for the future of glaucoma management.
By Lauren S. Blieden, MD, Bac T. Nguyen, MD
Phacoemulsification at Physiologic IOP: Benefits and Limitations
Higher pressures may be appropriate in some cases, but performing cataract surgery at lower IOP may lead to better patient outcomes.
By Shivani S. Kamat, MD, Mohamed R. Mohamed, MD
Ultrathin Shunt Shows Promising Results in Trial
In interim data presented at AGS, the VisiPlate glaucoma drainage device demonstrated significant IOP and medication reductions with a favorable safety profile.
By Jim Gallagher, senior managing editor
Restoring the Suprachoroidal Pathway?
Two-year data from the CREST trial, presented at AGS, shows a statistically significant reduction in IOP and medications.
By Jim Gallagher, senior managing editor
Departments
From the Editor: Risk Estimation Errors in Glaucoma Treatment
By Nathan M. Radcliffe, MD
Spotlight: Innovative Device Targets Eye Pressure Without Surgery or Meds
The FYSX Ocular Pressure Adjusting Pump is the first nonpharmacological, nonsurgical glaucoma treatment approved by the FDA.
By Karen Appold, contributing writer
Coding: The Growth Rate of MIGS Within Part B Medicare
A decade of rapid growth of MIGS may attenuate with more regulation.
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO